Company / Profit Margin
Zomedica Corp. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-255.6%
FY2025
5-year range
-255.6% / -89.9%
FY2022-FY2025
Trend
-48.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has declined for 3 consecutive years, from -89.9% in FY2022 to -255.6% in FY2025.
Based on SEC 10-K filings.
-255.6% in FY2025 with a 3-year CAGR of -165.7%.
Declined from -137.1% to -255.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -165.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Zomedica Corp.'s profit margin has declined for 3 consecutive years.
- In FY2025, profit margin decreased 48.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -255.6% | -48.4% |
| FY2024 | -172.2% | -25.6% |
| FY2023 | -137.1% | -52.5% |
| FY2022 | -89.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026